Jobubu Jarum Minahasa Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Jobubu Jarum Minahasa Tbk trades at Rp81 (market cap 324B, 5.1M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Jobubu Jarum Minahasa Tbk and Diagnos Laboratorium Utama Tbk. are close in size by market cap, and Jobubu Jarum Minahasa Tbk is more actively traded (5.1M versus 159.2K). Which is the better fit depends on your goals.
| BEER | DGNS | |
|---|---|---|
Market Cap | 324B | 310.75B |
Volume | 5.1M | 159.2K |
Lot | 50.98K | 1.59K |
Turnover | 402.52M | 34.72M |
Average Price | 78.96 | 218.06 |
Value | 402.52M | 34.72M |
Indicative Equilibrium Price | 81 | 220 |
Indicative Equilibrium Volume | 250 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT Jobubu Jarum Minahasa Tbk (the “Company”) was established based on Notarial Deed No. 19 of Theomaris Eddy Boham, S.H., M.H., dated July 25, 2018. The Company started its commercial operations since December 2018. The majority shareholder of the Company is PT Maju Minuman Minahasa and the Company's Ultimate Beneficiary Owner (UBO) is Nico Lieke.
Read more on BEER →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →